RxDoctor Payments Data

Hani Agrama, MD

Vascular Surgery · Rockledge, FLNPI 1285627380

Payments from drug & device makers

$635in general payments, 2019–2025

Across 32 payments — averaging $19.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Organogenesis Inc.$191
  • Smith+Nephew$108
  • Paratek Pharmaceuticals, Inc.$105
  • Convatec Inc.$34
  • Kerecis Limited$29
  • Reprise Biomedical, Inc.$25
  • plus $144 from 9 others

What the payments were for

  • Food & beverage$635100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Organogenesis Inc.8$191
Smith+Nephew6$108
Paratek Pharmaceuticals, Inc.5$105
Convatec Inc.2$34
Kerecis Limited1$29
Reprise Biomedical, Inc.1$25
Lifenet Health1$23
Solventum Corporation1$19
Molnlycke Health Care US, LLC1$18
Mimedx Group, Inc.1$15
OVIK Health, LLC1$15
Cashflow Solutions, LLC1$15
Tactile Systems Technology Inc1$14
Reapplix Inc.1$12
RGH Enterprises LLC1$12

How this compares

$635 in reported general payments places this provider in the 10th percentile of 385 vascular surgery providers in Florida.

See all vascular surgery providers in Florida

Medicare billing

Part B allowed, 2024
$40,578
Medicare patients
122
Services billed
539

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban11$6,431
Gentamicin Sulfate36$2,006
Mupirocin30$227
Triamcinolone Acetonide16$98

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Rockledge

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →